Literature DB >> 2275217

Physiological pharmacokinetic modelling.

L P Balant1, M Gex-Fabry.   

Abstract

1. The different types of models are described, with emphasis on the clearance-based one-compartment model, and on full physiological models which distinguish between a number of anatomical compartments interconnected through the body fluid system. 2. The clearance-based, one-compartment model incorporates physiological concepts, such as apparent volume of distribution, systemic availability, hepatic and renal clearance. As opposed to the classical rate constant-based model, it allows a study of the influence of plasma protein binding, hepatic intrinsic clearance and blood flow. The advantages of such an approach are illustrated in two typical situations, namely renal insufficiency and saturable protein binding. 3. In full physiological models each compartment represents a particular organ or tissue, further divided into vascular, interstitial and cellular spaces. Mass balance equations are written for each of these subcompartments. Shortcomings of such comprehensive models include difficulty in collecting tissue data, especially human, and sophisticated numerical techniques needed for parameter estimation. The main advantages are specific organ metabolism and transport, and the possibility of scaling up from animal to human. 4. The pharmacokinetic parameters important for new drug registration are also listed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2275217     DOI: 10.3109/00498259009046841

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  3 in total

Review 1.  Perspectives in pharmacokinetics. Physiologically based pharmacokinetic modeling as a tool for drug development.

Authors:  S B Charnick; R Kawai; J R Nedelman; M Lemaire; W Niederberger; H Sato
Journal:  J Pharmacokinet Biopharm       Date:  1995-04

2.  Population toxicokinetics of benzene.

Authors:  F Y Bois; E T Jackson; K Pekari; M T Smith
Journal:  Environ Health Perspect       Date:  1996-12       Impact factor: 9.031

3.  Species-specific pharmacokinetics of styrene in rat and mouse.

Authors:  J G Filser; U Schwegler; G A Csanády; H Greim; P E Kreuzer; W Kessler
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.